Carnegie Mellon’s Joel McManus and Pitt’s Robert Nicholls received a $162,000 grant from the Foundation for Prader-Willi Research to study the regulation and function of a key gene that is usually ...

The new Prescription Drug User Fee Act (PDUFA) date for diazoxide choline extended-release (DCCR) is slated for 27 March 2025 ...

New Epidemiological Insights into Mydriasis Reveal Projected Increase in Eye Exams and Surgeries Through 2034Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Prader-Willi Syndrome - Epidemiology ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the closing of the sale of its Rare Pediatric Disease Priority ...

A recent epidemiology forecast provides an extensive review of Prader-Willi Syndrome (PWS), projecting the evolution of the disease through 2034. This report intends to furnish healthcare ...

A mother from Kent is launching a foundation in memory of her son to help others with disabilities learn high-end ...

According to Soleno Therapeutics, the FDA required more time to review responses to recent information requests. The FDA has extended the review period for the NDA for DCCR tablets for the treatment ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

(SLNO) Tuesday announced that the FDA has extended the review period for the New Drug Application for DCCR tablets targeted at patients with Prader-Willi syndrome. DCCR is a proprietary extended ...

A Christmas concert attended by more than 500 people has raised £17,000 for an Oxford children's hospice. Helen & Douglas House held the festive event at Christ Church Cathedral on November 28.